Поисковый запрос: (<.>A=Kitakaze, Masafumi$<.>) |
Общее количество найденных документов : 55
Показаны документы с 1 по 20
|
|
1.
| Kitakaze Treatment or prophylaxis of ischemic heart disease
|
2.
| Asakura Cardioprotection in the clinical setting-lessons from J-WIND studies // Cardiov. Drugs and Ther., 2010. Vol. 24, N 3.-С.289-295
|
3.
| Left atrial volume combined with atrial pump function identifies hypertensive patients with a history of paroxysmal atrial fibrillation // Hypertension, 2010. Vol. 55, N 5.-С.1150-1156
|
4.
| Kitakaze How to mediate cardiprotection in ischemic hearts - accumulated evidence of basic research should translate to clinical medicine // Cardiov. Drugs and Ther., 2010. Vol. 24, N 3.-С.217-223
|
5.
| Asakura Cardioprotection in the clinical setting-lessons from J-WIND studies // Cardiov. Drugs and Ther., 2010. Vol. 24, N 3.-С.289-295
|
6.
| Aldosterone nongenomically worsens ischemia via protein kinase C-dependent pathways in hypoperfused canine hearts // Hypertension, 2005. Vol. 46, N 1.-С.113-117
|
7.
| Raloxifene prevents cardiac hypertrophy and dysfunction in pressure-overloaded mice // Hypertension, 2004. Vol. 43, N 2.-С.237-242
|
8.
| Treatment of dilated cardiomyopathy with electroporation of hepatocyte growth factor gene into skeletal muscle // Hypertension, 2004. Vol. 44, N 3.-С.365-371
|
9.
| UGT1A1 haplotypes associated with reduced glucuronidation and increased serum bilirubin in irinotecan-administered Japanese patients with cancer // Clin. Pharmacol. and Ther., 2004. Vol. 75, N 6.-С.501-515
|
10.
| Lesion severity and hypercholesterolemia determine long-term prognosis of vasospastic angina treated with calcium channel antagonists // Circ. J., 2003. Vol. 67, N 12.-С.1029-1035
|
11.
| Lesion severity and hypercholesterolemia determine long-term prognosis of vasospastic angina treated with calcium channel antagonists // Circ. J., 2003. Vol. 67, N 12.-С.1029-1035
|
12.
| Role of phasic dynamism of p38 mitogen-activated protein kinase activation in ischemic preconditioning of the canine heart // Circ. Res., 2001. Vol. 88, N 2.-С.175-180
|
13.
| Role of phasic dynamism of p38 mitogen-activated protein kinase activation in ischemic preconditioning of the canine heart // Circ. Res., 2001. Vol. 88, N 2.-С.175-180
|
14.
| Increased cardiac levels of nitric oxide in patients with chronic heart failure // Amer. J. Cardiol., 2000. Vol. 86, N 4.-С.474-477
|
15.
| Pravastatin restored the infarct size-limiting effect of ischemic preconditioning blunted by hypercholesterolemia in the rabbit model of myocardial infarction // J. Amer. Coll. Cardiol., 1999. Vol. 34, N 7.-С.2120-2125
|
16.
| Pravastatin restored the infarct size-limiting effect of ischemic preconditioning blunted by hypercholesterolemia in the rabbit model of myocardial infarction // J. Amer. Coll. Cardiol., 1999. Vol. 34, N 7.-С.2120-2125
|
17.
| Pravastatin restored the infarct size-limiting effect of ischemic preconditioning blunted by hypercholesterolemia in the rabbit model of myocardial infarction // J. Amer. Coll. Cardiol., 1999. Vol. 34, N 7.-С.2120-2125
|
18.
| A Ca channel blocker, benidipine, increases coronary blood flow and attenuates the severity of myocardil ischemia via NO-dependent mechanisms in dogs // J. Amer. Coll. Cardiol., 1999. Vol. 33, N 1.-С.242-249
|
19.
| A Ca channel blocker, benidipine, increases coronary blood flow and attenuates the severity of myocardil ischemia via NO-dependent mechanisms in dogs // J. Amer. Coll. Cardiol., 1999. Vol. 33, N 1.-С.242-249
|
20.
| Role of Ca{2+}-activated K{+} channels in the protective effect of ACE inhibition against ischemic myocardial injury // Hypertension, 1998. Vol. 31, N 6.-С.1290-1298
|
&uf('+1W2226#',v2226), ?>
|
|